MRC Technology, Newsummit Biopharma deal

Medical research charity MRC granted Newsummit rights to develop an undisclosed antibody to treat HCV infection. The antibody was discovered by MRC-University of Glasgow Centre for Virus Research (Glasgow, U.K.) and humanized by MRC. ...